Almasry Pharmacy

Anastrozol 1 Mg 30 Tablets

Short Description:
Anastrozol 1 mg 30 tablets is a prescription aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer, mainly in postmenopausal women. It lowers estrogen levels to help slow or stop the growth of estrogen-dependent tumors and is taken once daily under specialist medical supervision.

EGP 495

In Stock

delivery-iconDelivery to governorates within 3-4 working days
refund-iconEasy returns within 14 days
Specifications
SKUISG000197
BrandSandozLink Icon
Categories
Medication & Treatments
Color
Luscious Blackberry
Concentrations
1 Mg
Shop by ConcernsCancer Recurrence RiskLink Icon, Estrogen-Dependent TumorsLink Icon, Hormone Receptor Positive Breast CancerLink Icon
Gender
Female
Shop By GoalsBreast Cancer ManagementLink Icon, Hormone ModulationLink Icon, Tumor Growth ControlLink Icon
Imported Or LocalLocal
Ingredient
Anastrozole
UPC
4030855503780
Product Form
Tablets
Specialty
Clinically Tested
Non-Steroidal Inhibitor
Oncologist Prescribed
Sub Categories
Chemotherapy & Immunosuppresants
Unit Count
30 Tablets
Warning
May decrease bone density
Not for use in case of pregnancy or breastfeeding
Prescription only
Use with caution in liver and kidney impairment
About the product›

Anastrozol 1 Mg 30 Tablets

Description:

Anastrozol 1 mg 30 tablets (anastrozol-sandoz 1 mg film-coated tablets) is a prescription anticancer medicine used in the management of hormone receptor-positive breast cancer. It belongs to the class of non-steroidal aromatase inhibitors, which reduce estrogen production in the body. Lowering estrogen levels helps slow or stop the growth of certain types of breast tumors that depend on estrogen. This product is intended for use under the supervision of an oncologist or specialist physician and is not a supplement or over-the-counter health aid.


Indications:

  • Treatment of hormone receptor-positive early breast cancer in postmenopausal women, usually after surgery (adjuvant therapy).
  • Treatment of advanced or metastatic breast cancer in postmenopausal women whose tumors are estrogen receptor-positive or hormone-responsive.
  • May be used as first-line therapy for advanced breast cancer in postmenopausal women, as directed by an oncologist.
  • May be used in women with breast cancer who have experienced disease progression following tamoxifen therapy, according to medical guidance.
  • Helps reduce estrogen-driven tumor growth, breast pain related to hormone-sensitive tumors, and disease progression in appropriate patients.

Active Ingredients / Key Components:

  • Anastrozole – 1 mg per film-coated tablet.
  • Other tablet excipients (such as fillers, binders, coating agents, and colorants) are present, but the full excipient list and their concentrations , please check the product leaflet or the manufacturer’s official website.

Dosage & Administration / How to Use:

  • Usual adult dose: 1 mg anastrozole (one tablet) taken once daily, or as prescribed by the treating oncologist.
  • Tablets should be swallowed whole with a glass of water; do not crush, chew, or split unless your doctor or pharmacist specifically advises otherwise.
  • Can be taken with or without food; try to take it at the same time each day to maintain consistent blood levels.
  • Treatment duration is long term and is determined by your doctor, often for several years in early breast cancer, or as long as clinical benefit is observed in advanced disease.
  • If you miss a dose, take it as soon as you remember on the same day. If it is almost time for the next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed tablet.
  • Do not stop taking anastrozol without consulting your doctor, even if you feel well, as stopping treatment may increase the risk of cancer progression or recurrence.
  • Use only under strict medical supervision, with regular follow-up, blood tests, and imaging as recommended by your oncologist.

Clinical Benefits:

  • Reduces estrogen production by inhibiting the aromatase enzyme, thereby limiting hormone stimulation of estrogen receptor-positive breast cancer cells.
  • Helps decrease the risk of recurrence and disease progression in hormone receptor-positive early breast cancer after surgery.
  • Provides effective control of advanced or metastatic hormone-sensitive breast cancer in postmenopausal women, improving disease-free intervals.
  • May delay the need for more aggressive treatments such as chemotherapy in selected patients, as part of a comprehensive treatment plan.
  • Offers an oral, once-daily treatment option, improving convenience and adherence compared with some injectable therapies.

Warnings & Contraindications:

  • Contraindicated in pregnancy and breastfeeding; anastrozol must not be used by women who are pregnant, planning pregnancy, or nursing.
  • Not indicated for use in premenopausal women unless specifically directed and closely monitored by a specialist; hormone status should be confirmed before starting therapy.
  • Contraindicated in patients with known hypersensitivity or allergy to anastrozole or any of the tablet excipients.
  • Use with caution in patients with moderate to severe liver impairment; liver function should be monitored regularly as advised by the physician.
  • Use with caution in patients with severe kidney impairment; dose adjustment may be considered by the treating doctor.
  • Anastrozole may reduce bone mineral density and increase the risk of osteoporosis and fractures; baseline and periodic bone density assessment (DEXA scan) may be recommended.
  • Inform your doctor if you have a history of osteoporosis, low bone mineral density, fractures, high cholesterol, cardiovascular disease, or blood clotting disorders.
  • May affect cholesterol levels; lipid profile monitoring may be required in long-term use.
  • Do not use concurrently with estrogen-containing therapies (such as hormone replacement therapy), as they can reduce the effectiveness of anastrozole.
  • Consult your doctor before use if you are taking any other medications, including tamoxifen, other hormonal agents, anticoagulants, or over-the-counter supplements, to avoid interactions.
  • May cause dizziness or fatigue in some patients; use caution when driving or operating machinery until you know how the medicine affects you.
  • Consult your doctor before use if you have or have had liver disease, kidney disease, osteoporosis, low vitamin d levels, or cardiovascular disease.
  • Keep out of reach of children.

Side Effects:
  • Common side effects may include hot flashes, sweating, fatigue, weakness, headache, nausea, vomiting, diarrhea, constipation, joint pain (arthralgia), muscle pain, and mild skin rash.
  • Other possible effects include mood changes, depression, sleep disturbances, hair thinning, weight changes, and increased cholesterol levels.
  • Long-term use may be associated with decreased bone mineral density, osteoporosis, and an increased risk of bone fractures.
  • Serious but less common side effects may include severe allergic reactions (swelling of face, lips, tongue, or throat; difficulty breathing), severe skin reactions, chest pain, signs of blood clots (sudden shortness of breath, leg swelling), or signs of liver problems (yellowing of skin or eyes, dark urine, severe abdominal pain).
  • Seek immediate medical attention if you experience symptoms of a serious allergic reaction, chest pain, sudden shortness of breath, severe or persistent bone pain, or any unusual or severe symptoms.
  • Always report persistent, bothersome, or unexpected side effects to your doctor or pharmacist.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed in its original blister pack or carton to protect from moisture. Do not store above the temperature specified on the package (exact storage temperature is not available in the provided information; follow the product label). Keep out of reach of children.


Specifications:
  • Product type: Prescription anticancer medicine (non-steroidal aromatase inhibitor).
  • Strength: 1 mg anastrozole per film-coated tablet.
  • Form: Tablet.
  • Pack size: 30 tablets per pack.
  • Intended user group: Primarily postmenopausal women with hormone receptor-positive breast cancer, as prescribed by a specialist.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.

Product Reviews

Overall Rating
0

Based on 0 reviews

Warning iconYou can add a rating once you purchase the product through the My Orders page

Customer Reviews
No reviews yet
TelegramWhatsApp